Talis Biomedical Corporation - common stock (TLIS)
4.3800
+0.00 (0.00%)
Talis Biomedical Corp is a biotechnology company focused on developing innovative diagnostic solutions for infectious diseases
The company aims to enhance the speed and accuracy of pathogen detection through its proprietary technology platform, which integrates molecular diagnostics with advanced automation. By creating devices that can deliver rapid test results, Talis seeks to improve patient care and facilitate timely decision-making in clinical environments, particularly in the context of critical conditions where early diagnosis is essential.
Talis Biomedical shares are trading lower by 49% to $4.58 during Wednesday's session. The company announced board restructuring, appointed new directors and updated investors on potential bankruptcy proceedings.
Talis Biomedical Corp (NASDAQ: TLIS) shares are trading higher by 30% to $7.03 Tuesday morning after the company announced it is exploring strategic options to boost shareholder value due to
U.S. stocks traded higher, with the Dow Jones gaining around 500 points on Tuesday. Shares of Azenta, Inc. (NASDAQ: AZTA) rose on Tuesday after the company reported better-than-expected fourth-quarter financial results.
Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 209.5% to $2.29 after the company signed a Letter of Intention with UAE-Based e-script medicine management company Pharmak Pharmacy.
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares gained 110.8% to $1.56 in pre-market trading after the company signed a Letter of Intention with UAE-Based e-script medicine management company Pharmak Pharmacy.
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its first quarter.
